Skip to Main Content

Stephanie O'Malley, PhD


Elizabeth Mears and House Jameson Professor of Psychiatry; Deputy Chair, Clinical Research

Dr. O’Malley’s research focuses on behavioral pharmacology, clinical trials of psychosocial and behavioral interventions with substance abusers, and studies of risk for alcoholism and nicotine dependence. Dr. O'Malley is co-Director of the Clinician Scientist Program, teaches in the core seminars, holds a Senior Scientist and Mentoring K05 and has mentored multiple past and current trainees and other junior faculty members including many women who are now internationally renowned addictions researchers. Dr. O’Malley has made seminal contributions to addiction treatment, including having conducted initial investigations of naltrexone, including one of the two pivotal studies used in the FDA approval of naltrexone for alcohol dependence and the development of a laboratory alcohol self-administration model that has been used by NIH, pharma and academic investigators to evaluate several compounds for alcoholism. She has made substantial contributions to tobacco research through her leadership of the Transdisciplinary Tobacco Use Research Center at Yale, funded by NIDA, NCI and NIAAA. She has an exceptional track record of leadership within the Department of Psychiatry as the Director of the Division of Addictions (DA), as the President of the Research Society on Alcoholism, and as a leader of multi-site clinical trials and transdisciplinary research.